Updates are available Correction dated 2026-03-18
Click to view Correction: https://doi.org/10.1038/s41386-026-02387-1
-
Authors
Lenze, Eric J.
Karp, Jordan F.
Gebara, Marie Anne
Nicol, Ginger E. https://orcid.org/0000-0001-5823-6129
Mulsant, Benoit H. https://orcid.org/0000-0002-0303-6450
- License Information
-
More Information
Article History
Received: 1 August 2025
Revised: 11 September 2025
Accepted: 20 November 2025
First Online: 19 February 2026
Change Date: 18 March 2026
Change Type: Update
Change Details: The original online version of this article was revised: figure legend and section title have been updated.
Change Date: 18 March 2026
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41386-026-02387-1
Competing interests
: Dr. Lenze has received research support from the Patient Centered Outcomes Research Center (PCORI), COVID Early Treatment Fund, Mercatus Center Emergent Ventures, Balvi Philanthropic Fund, Pritikin, and the XPrize Foundation. Dr. Karp receives research support from Johnson & Johnson Neuroscience. He has served as a scientific advisor for Johnson & Johnson Neuroscience, Otsuka, Biogen, and Aifred Health. He receives support from NIH, the Patient Centered Outcomes Research Center (PCORI), and HRSA. Dr. Gebara has received compensation from Otsuka for developing and presenting a disease-state webinar and research support from Janssen. Dr. Nicol has served as a Co-Investigator or Principal Investigator for studies funded by COMPASS Pathways, LB Pharmaceuticals, Inc., Alkermes, and Usona Institute (drug only). She has served as a consultant for Carelon. Dr. Mulsant holds and receives support from the Labatt Family Chair in Biology of Depression in Late-Life Adults at the University of Toronto. He currently receives or has received with the past 5 years, research support from Brain Canada, the Canadian Institutes of Health Research (CIHR), the CAMH Foundation, the Patient-Centered Outcomes Research Institute (PCORI), the US National Institute of Health (NIH), Capital Solution Design LLC (software used in a study founded by CAMH Foundation) and HAPPYneuron (software used in a study founded by Brain Canada).
